Ikapharmindo Putramas Tbk. vs Super Bank Indonesia Tbk. — how do they compare? Ikapharmindo Putramas Tbk. trades at Rp183 (market cap 304.92B, 13.7K 24h volume), while Super Bank Indonesia Tbk. trades at Rp585 (market cap 19.46T, 10.03M 24h volume). The key difference: Super Bank Indonesia Tbk. is far larger — about 63.8× Ikapharmindo Putramas Tbk.'s market cap, and Super Bank Indonesia Tbk. is more actively traded (10.03M versus 13.7K). Which is the better fit depends on your goals.
| IKPM | SUPA | |
|---|---|---|
Market Cap | 304.92B | 19.46T |
Volume | 13.7K | 10.03M |
Lot | 137 | 100.32K |
Turnover | 2.49M | 5.86B |
Average Price | 181.39 | 584.5 |
Value | 2.49M | 5.86B |
Indicative Equilibrium Price | — | 585 |
Indicative Equilibrium Volume | — | 2.54K |
Trailing returns across standard periods
Latest headlines on both assets
PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →PT Super Bank Indonesia Tbk. (hereinafter referred to as the Bank) formerly under the name of PT Bank Fama International was established by Deed No. 36 on 5 March 1993, before Notary Herlien, S.H. The Bank has received a license as a commercial bank according to the Decree of the Minister of Finance of the Republic of Indonesia No. 834/KMK.017/1993 dated 11 October 1993.
Read more on SUPA →